Insulin Family intermediate
Insulin Degludec/Aspart 70:30
Co-formulation of ultra-long-acting insulin degludec and rapid-acting insulin aspart for basal-bolus coverage.
By Encyclopeptide Editorial | 1 min read
insulin degludec aspart combination diabetes
Chemical Identity
| Property | Value |
|---|---|
| Product Name | Ryzodeg 70/30 |
| Components | Insulin degludec + Insulin aspart |
| Fixed Ratio | 70:30 (degludec:aspart) |
Clinical Applications
Indicated for type 1 and type 2 diabetes. Provides basal-bolus coverage with fewer injections than separate basal-bolus regimens.
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “Insulin Degludec/Aspart 70:30” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Degludec/Aspart 70:30 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept